Details for New Drug Application (NDA): 205438
✉ Email this page to a colleague
NDA 205438 describes TRIFLURIDINE, which is a drug marketed by Hikma and Sandoz and is included in two NDAs. It is available from one supplier. Additional details are available on the TRIFLURIDINE profile page.
The generic ingredient in TRIFLURIDINE is trifluridine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trifluridine profile page.
The generic ingredient in TRIFLURIDINE is trifluridine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trifluridine profile page.
Summary for 205438
| Tradename: | TRIFLURIDINE |
| Applicant: | Hikma |
| Ingredient: | trifluridine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205438
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Jul 28, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
